QQQ   310.07 (+3.04%)
AAPL   149.76 (+2.98%)
MSFT   261.40 (+3.42%)
META   188.80 (+23.30%)
GOOGL   106.81 (+6.35%)
AMZN   111.36 (+5.91%)
TSLA   192.54 (+6.14%)
NVDA   212.47 (+1.45%)
NIO   12.07 (-0.25%)
BABA   108.09 (-4.19%)
AMD   87.51 (+3.39%)
T   20.45 (+1.34%)
MU   62.32 (-0.45%)
F   14.49 (+5.08%)
CGC   3.11 (+0.97%)
GE   82.79 (+0.57%)
DIS   112.25 (+2.61%)
AMC   6.19 (+8.41%)
PFE   44.00 (+0.07%)
PYPL   87.59 (+5.64%)
NFLX   365.10 (+0.86%)
QQQ   310.07 (+3.04%)
AAPL   149.76 (+2.98%)
MSFT   261.40 (+3.42%)
META   188.80 (+23.30%)
GOOGL   106.81 (+6.35%)
AMZN   111.36 (+5.91%)
TSLA   192.54 (+6.14%)
NVDA   212.47 (+1.45%)
NIO   12.07 (-0.25%)
BABA   108.09 (-4.19%)
AMD   87.51 (+3.39%)
T   20.45 (+1.34%)
MU   62.32 (-0.45%)
F   14.49 (+5.08%)
CGC   3.11 (+0.97%)
GE   82.79 (+0.57%)
DIS   112.25 (+2.61%)
AMC   6.19 (+8.41%)
PFE   44.00 (+0.07%)
PYPL   87.59 (+5.64%)
NFLX   365.10 (+0.86%)
QQQ   310.07 (+3.04%)
AAPL   149.76 (+2.98%)
MSFT   261.40 (+3.42%)
META   188.80 (+23.30%)
GOOGL   106.81 (+6.35%)
AMZN   111.36 (+5.91%)
TSLA   192.54 (+6.14%)
NVDA   212.47 (+1.45%)
NIO   12.07 (-0.25%)
BABA   108.09 (-4.19%)
AMD   87.51 (+3.39%)
T   20.45 (+1.34%)
MU   62.32 (-0.45%)
F   14.49 (+5.08%)
CGC   3.11 (+0.97%)
GE   82.79 (+0.57%)
DIS   112.25 (+2.61%)
AMC   6.19 (+8.41%)
PFE   44.00 (+0.07%)
PYPL   87.59 (+5.64%)
NFLX   365.10 (+0.86%)
QQQ   310.07 (+3.04%)
AAPL   149.76 (+2.98%)
MSFT   261.40 (+3.42%)
META   188.80 (+23.30%)
GOOGL   106.81 (+6.35%)
AMZN   111.36 (+5.91%)
TSLA   192.54 (+6.14%)
NVDA   212.47 (+1.45%)
NIO   12.07 (-0.25%)
BABA   108.09 (-4.19%)
AMD   87.51 (+3.39%)
T   20.45 (+1.34%)
MU   62.32 (-0.45%)
F   14.49 (+5.08%)
CGC   3.11 (+0.97%)
GE   82.79 (+0.57%)
DIS   112.25 (+2.61%)
AMC   6.19 (+8.41%)
PFE   44.00 (+0.07%)
PYPL   87.59 (+5.64%)
NFLX   365.10 (+0.86%)
OTCMKTS:PMCB

PharmaCyte Biotech - PMCB Stock Forecast, Price & News

$2.89
0.00 (0.00%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.83
$2.92
50-Day Range
$2.72
$3.07
52-Week Range
$1.79
$3.10
Volume
95,818 shs
Average Volume
65,322 shs
Market Capitalization
$54.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PMCB stock logo

About PharmaCyte Biotech (OTCMKTS:PMCB) Stock

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Receive PMCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter.

PMCB Stock News Headlines

PharmaCyte to evaluate opportunities; CEO steps down
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
PharmaCyte Biotech Shares Reverse Course, Drop 8%
PharmaCyte Biotech reports Q3 results
See More Headlines
Receive PMCB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmaCyte Biotech and its competitors with MarketBeat's FREE daily newsletter.

PMCB Company Calendar

Last Earnings
12/14/2022
Today
2/02/2023
Fiscal Year End
4/30/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PMCB
Employees
4
Year Founded
N/A

Profitability

Net Income
$-4,240,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.34 per share

Miscellaneous

Free Float
17,673,000
Market Cap
$54.13 million
Optionable
Not Optionable
Beta
0.04

Key Executives

  • Joshua Nathaniel Silverman
    Chairman, President & Chief Executive Officer
  • Carlos A. Trujillo
    Chief Financial Officer
  • José L. Iglesias
    Chief Medical Officer
  • Lilli Brandtner
    Director-Diabetes Program Development













PMCB Stock - Frequently Asked Questions

How have PMCB shares performed in 2023?

PharmaCyte Biotech's stock was trading at $2.93 at the start of the year. Since then, PMCB stock has decreased by 1.4% and is now trading at $2.89.
View the best growth stocks for 2023 here
.

How were PharmaCyte Biotech's earnings last quarter?

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) announced its quarterly earnings results on Wednesday, December, 14th. The company reported ($0.09) EPS for the quarter.

What other stocks do shareholders of PharmaCyte Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PharmaCyte Biotech investors own include Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Vaxart (VXRT), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), OWC Pharmaceutical Research (OWCP), VBI Vaccines (VBIV) and Novavax (NVAX).

What is PharmaCyte Biotech's stock symbol?

PharmaCyte Biotech trades on the OTCMKTS under the ticker symbol "PMCB."

Who are PharmaCyte Biotech's major shareholders?

PharmaCyte Biotech's stock is owned by many different retail and institutional investors. Top institutional shareholders include FNY Investment Advisers LLC (0.17%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of PharmaCyte Biotech?

Shares of PMCB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PharmaCyte Biotech's stock price today?

One share of PMCB stock can currently be purchased for approximately $2.89.

How much money does PharmaCyte Biotech make?

PharmaCyte Biotech (OTCMKTS:PMCB) has a market capitalization of $54.13 million. The company earns $-4,240,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis.

How can I contact PharmaCyte Biotech?

PharmaCyte Biotech's mailing address is 23046 AVENIDA DE LA CARLOTA SUITE 600, LAGUNA HILLS CA, 92653. The official website for the company is www.pharmacyte.com. The company can be reached via phone at (917) 595-2850, via email at info@pharmacyte.com, or via fax at 917-595-2851.

This page (OTCMKTS:PMCB) was last updated on 2/2/2023 by MarketBeat.com Staff